DiaSorin
Roche, Diasorin, Siemens Healthineers, Others Gain 510(k) Clearances in April
April's clearances included respiratory disease assays, a Gram-negative infection test, and assays to aid the diagnosis and monitoring of thyroid disease.
Diasorin Q1 Revenues Rise 8 Percent
The firm reported growth across its immunodiagnostics and molecular diagnostics businesses as well as contributions from the firm's licensed technologies business.
Diasorin Nabs FDA 510(k) Clearance for Gram-Negative Bloodstream Infection Panel
The firm's Liaison Plex Gram-Negative Blood Culture Assay is used for the identification of 19 Gram-negative bacteria and eight resistance genes.
Diasorin Nabs CE-IVDR Marking for Candida Auris PCR Assay
The Simplexa C. auris Direct kit is a real-time PCR assay that is used for the detection of DNA from six clades of the fungal pathogen in patients with suspected colonization.
Excluding COVID-19 Business, Diasorin 2024 Revenues Rise 6 Percent as ImmunoDx Revenues Jump
The firm said that a strong start to the commercialization of its Liaison Plex platform also aided growth in its molecular diagnostics business.